Why the study?
Are hemodynamic markers of pulmonary hypertension associated with mortality and cardiac hospitalizations in patients with HFpEF?
Are hemodynamic markers of pulmonary hypertension associated with mortality and cardiac hospitalizations in patients with HFpEF?
In patients with HFpEF, invasive hemodynamic markers of pulmonary hypertension are significantly associated with adverse clinical outcomes including mortality and cardiac hospitalizations.
Answers are grounded in this paper and cite their sources.
These markers may aid risk stratification in HFpEF; leaves open whether targeting them improves outcomes.
In a large cohort referred for invasive hemodynamic assessment, PH-HFpEF was common. Transpulmonary gradient, pulmonary vascular resistance, and diastolic pulmonary gradient are all associated with mortality and cardiac hospitalizations.
No takes yet. Share an insight, caveat, or question.
Vanderpool et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: